The Japanese Foundation for Cancer Research (JFCR), NEC Corporation, and Taiho Pharmaceutical Co. have signed a three-pa...
Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...
Sanofi and AstraZeneca's Beyfortus (Nirsevimab) is now approved (KKLIU 3697 / EXP 16.05.2026) by the National Pharmaceut...
A new intranasal influenza vaccine has been launched in Singapore, offering a needle-free option for individuals aged ...
US-based Apriori Bio and Singapore's Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) h...
Australia’s new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, has been l...
Nearly a decade after the world’s attention was gripped by the Zika virus outbreak in Brazil, the disease is quiet...
HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...
The vaccine landscape in Asia-Pacific is undergoing significant transformation and growth. While public-sector programme...
Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry o...
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as Nor...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...
Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Dia...
The Zambia National Public Health Institute (ZNPHI) and South Korea-based International Vaccine Institute (IVI) has sign...
Josephine Cheng, Senior Modality Leader, Process Solutions, Life Science Business of Merck The global pharmaceutic...
Australian children will now have stronger protection against pneumococcal with the Australian Government implementing a...
Australia-based Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for need...
